SamuelMSilverMDPhD, MACP, FRCP, FAHA, FASCO

PubMed

• 878 citations
  A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
  Jesse L. Goodman, Drew J. Winston, Ronald A. Greenfield, Pranatharthi H. Chandrasekar, Barry C. Fox
  The New England Journal of Medicine. 1992-03-26
• 27 citations
  Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation.
  S M Silver, A Scheid, Purnell W. Choppin
  Infection and Immunity. 1978-04-01
• 3 citations
  Erythropoietin-stimulating agents in oncology.
  Michael R. Savona, Samuel M. Silver
  Cancer Journal. 2008-03-01

Journal Articles

• Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria  
  Manisha Balwani, M.D., Eliane Sardh, M.D., Ph.D., Paolo Ventura, M.D., Paula Aguilera Peiró, M.D., David C. Rees, F.R.C.P., Ulrich Stölzel, M.D., D. Montgomery Bissell..., New England Journal of Medicine, 6/11/2020
• The devil’s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda  
  B Sunkara, D Roofeh, S Silver, T LeBleu Pearson, M Ettel and WJ McCune, Lupus (2018) 27, 1383–1386, 2018
• Phase I Study of Involved Field Radiation Therapy Preceding High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With High-Risk Hodgkin’s Diseas...  
  Dawson L, Saito N, Ratanatharathorn V, Uberti JP, Adams PT, Ayash L, Reynolds C, Silver SM, Schipper MS, Lichter AS, Eisbruch A, International Journal of Radiation Oncology Biology Physics
• Cancer Care for the Whole Patient- A New Institute of Medicine Report.  
  Silver SM, Journal of Oncology Practice
• Erythropoietin’s in Oncology: Current Status.  
  Savona Michael R and Silver SM, Journal of Principles & Practice of Oncology
• National Comprehensive Cancer Network. Breast cancer.  
  Carlson RW. Anderson BO. Burstein HJ. Cox CE. Edge SB. Farrar WB. Goldstein LJ. Gradishar WJ. Hayes DF. Hudis C. Jahanzeb M. Ljung BM. Marks LB. McCormick B. Nabell ..., Journal of the National Comprehensive Cancer Network
• The American Society of Hematology: Advancing Knowledge and Treatment of Blood Disorders.  
  Silver SM, J Oncology Practice
• National Comprehensive Cancer Network. NCCN Practice Guidelines for Breast Cancer.  
  Carlson RW. Anderson BO. Bensinger W. Cox CE. Davidson NE. Edge SB. Farrar WB. Goldstein LJ. Gradishar WJ. Lichter AS. McCormick B. Nabell LM. Reed EC. Silver SM. Sm..., J National Comprehensive Cancer Network
• Current Thinking on the Use of ABMT in Breast Cancer Patients.  
  Adams PT, Mule J, Silver SM, Ratanatharathorn V, and Uberti J, Michigan Oncology Journal
• The Adoption and Impact of Personalized Medicine: Gene Expression Profile Testing and Chemotherapy for Breast Cancer.  
  Hassett MJ, & Silver SM, (co-1st authors), Hughes ME, Ali HY, Blayney DW, Caughran J, Edge SB, Herman JE, Hudis CA, Laronga C, Kelly Marcom P, Pettinga JE, Share D..., Journal of Clinical Oncology
• Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.  
  Ayash LJ, Ratanatharathorn V, Braun T, Silver SM, Reynolds CM, Uberti JP, American Journal of Hematology
• Change in rate-determining steps for a simple carbonyl addition reaction. Kinetically significant proton transfer step in acid-catalyzed O-methyloxime formation.  
  Silver SM and Sayer JM, J Amer Chem Soc
• Clinical trials: are they a good buy?  
  Bennett CL. Adams JR. Knox KS. Kelahan AM. Silver SM. Bailes JS, Journal of Clinical Oncology
• A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.  
  Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman H, Powderly WG, Silber J, Horowitz H, Lichtin A, Wolff..., New England Journal of Medicine
• Structure of the platelet membrane glycoprotein IIb: Homology to the alpha subunit of the vitronectin and fibronectin membrane receptors.  
  Poncz M, Eisman R, Heidenreich R, Silver SM, Vilaire G, Surrey S, Schwartz E and Bennett JS, J Biol Chem
• The Proteins of Measles Virus and Their Synthesis in Infected Cells.  
  Silver SM, Doctoral Thesis, Rockefeller University
• Measles virus polypeptide synthesis in infected cells.  
  Graves MC, Silver SM and Choppin PW, Virology
• Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation.  
  Silver SM, Scheid A and Choppin PW, Infect Immun
• Total synthesis of (+ OR-) –beta-gorgonene.  
  Boeckman RK; Silver SM, Journal of Organic Chemistry
• Evidence for two concurrent mechanisms and a kinetically significant proton transfer process in acid-catalyzed O-methyloxime formation.  
  Rosenberg S, Silver SM, Sayer JM and Jencks WP, J Am Chem Soc
• Synthesis of the nonisoprenoid sesquiterpene, beta-gorgonene.  
  Boeckman RK, JR and Silver SM, Tetrahedron Letters
• Join now to see all

Books/Book Chapters

• Studies on the structure and functions of paramyxovirus glycoproteins. 
  Chapter: Negative Strand Viruses and the Host Cell 
  Page 181 - 193Scheid A, Graves MC, Silver SM and Choppin PWEditors: BWJ Mahy and RD Barry.Academic Press, London
• Bone Marrow Transplantation. 
  Chapter: Schmaier A and Petruzzelli LM 
  Page 247 - 258Uberti J, Silver SM, and Ferrara J. LMEditors: Hematology for the Medical Student.Lippincott Williams & Wilkins, Philadelphia

Abstracts/Posters

• Risk Factors for Streptococcal Bacteremia in Bone Marrow Transplant Patients.
  Chenoweth C, Halpern M, Tibor K, and Silver SM, ICAAC, Am Soc Microbiol, Anaheim
• Use of a 21-gene reverse transcriptase-polymerase chain reaction (RT-PCR) assay to guide therapy in 14 Michigan breast oncology quality initiative (MiBOQI) sites.
  Silver SM, Ali HY, Blayney DW, Caughran J, Herman JG, Pettinga JE, Share D, Mehringer A, Hayes A, Vandergrift JL, Annual Meeting, Chicago, IL, J Clin Oncol
• Timing in adjuvant chemotherapy (CTX) initiation among women with breast cancer (BC) at national comprehensive cancer network (NCCN) centers: An analysis from the NC...
  Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis C, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC, ASCO Annual Meeting
• Sexual Functioning among Hematopoietic Cell Transplant Survivors and Partners.
  Langer S, Brown JD, Silver SM, Tierney DK, Matous J, Wingard J, McQuellon R, Yi J, Syrajala K, Biennial Meeting on Cancer Survivorship
• National Comprehensive Cancer Network Collaboration in Guidelines and Programs in Asia
  Silver, SM, Japanese Society of Clinical Oncology Annual Meeting, Nagoya, Japan
• Use of diagnostic testing for patients with early-stage breast cancer in a multi-hospital quality collaborative in Michigan.
  Tara M. Breslin, James Kubus, Haythem Y. Ali, T. Trevor Singh, Paul T. Adams, Angela Applewhite, Ann M. Mehringer, Samuel M. Silver, ASCO's Quality Care Symposium, San Diego
• Patterns of definitive axillary management in the era prior to reporting ACOSOG - Z0011: comparison between NCCN Centers and hospitals in Michigan.
  Breslin T, Hwang S, Mamet R, Ottesen R, Rugo H, Edge S, Hughes ME, Wilson J, Laronga C, Moy B, Weeks JC, Silver S, Marcom K, SABC, San Antonio
• Phase I/II High-Dose Chemotherapy with Autologous Stem Cell Support for Testis Cancer.
  Adams PT, Ayash L, Ratanatharathorn V, Broun ER, Uberti J, and Silver SM, The U of Michigan Experience, ASCO
• Typhlitis in a 36 Year Old Man with Acute Lymphocytic Leukemia.
  Shehab TM and Silver SM, American College of Physicians Michigan Chapter Annual Meeting
• Loss on serial passage of rhesus monkey kidney cells and proteolytic activity. Sendai Virus Activation.
  Silver SM, Scheid A and Choppin PW, Am Soc Microbiol
• Glycoproteins IIb and IIIa in K562 cells.
  Bennett JS, Vilaire G, McDonough M, Silver SM, Blood
• Isolation and characterization of platelet glycoprotein IIb cDNA clones from HEL cells.
  Poncz M, Silver SM, McDonough MM, LaRocca P, Surrey S, Schwartz E and Bennett JS, Circulation
• The platelet membrane glycoproteins IIb and IIIa are products of separate genes.
  Silver SM, McDonough MM, Vilaire G, Poncz M, Bennett JS, Clinical Res
• The genes for the platelet membrane glycoprotein-IIB and glycoprotein-IIIA are expressed by 2 human-leukemic cell-lines.
  Bennett JS; Vilaire G; Silver SM, Thrombosis and Haemostasis
• The gene for the platelet membrane glycoprotein IIb is expressed in human erythroleukemia (HEL) cells.
  Silver SM, Vilaire G, Bennett JS, Thrombosis and Haemostasis
• The gene for the platelet membrane glycoprotein IIIa is expressed by phorbol ester stimulated K-562 cells.
  Silver SM, Hoxie JA, Vilaire G and Bennett JS, Circulation
• The biologic role of host-dependent cleavage of viral glycoproteins.
  Choppin PW, Scheid A, Graves MC and Silver SM, ICN-UCLA Symp Molec and Cell Biol
• Measles virus polypeptide synthesis in infected cells.
  Graves MC, Silver SM and Choppin PW, Am Soc Microbiol
• Join now to see all

Lectures

• Breast Cancer- Medical Oncology Aspects. 
  Fifth National Cancer Conference, Bangkok, Thailand
• National Cancer Treatment Guideline Development. 
  Fifth National Cancer Conference, Bangkok, Thailand
• From the Comprehensive Cancer Center to the Community: Building the Bridges of the Future. 
  Fifth National Cancer Conference, Bangkok, Thailand
• National Comprehensive Cancer Network Collaboration in Guidelines and Programs in Asia. 
  Japanese Society of Clinical Oncology Annual Meeting, Nagoya, Japan
• The platelet membrane glycoproteins IIb and IIIa are products of separate genes. 
  American Federation for Clinical Research, Washington, D.C
• The Reality of Bone Marrow Transplantation: Cost of Care and Reimbursement Issues. 
  American Society of Hematology National Meeting, Seattle
• Clinical Networks in the Practice of Hematology. 
  American Society of Hematology National Meeting, Orlando
• Informatics in the Practice of Hematology. 
  American Society of Hematology National Meeting, San Diego
• Appropriate Patient Selection Criteria in Stem Cell Transplantation. 
  National Comprehensive Cancer Network, Third Annual Conference, Ft. Lauderdale
• Hematology and Oncology: Issues in Medical Malpractice. 
  Professional Liability Series, San Francisco
• Hematology and Oncology: Issues in Medical Malpractice 
  Professional Liability Series, Medical Malpractice Issues: What You Need to Win Your Case, Denver
• Clinical Trials in the Practice Setting. 
  Oncology President’s Retreat. Reston, Virginia
• Issues Affecting Our Organizations: The American Society of Hematology. 
  The Oncology President’s Retreat. Reston, Virginia
• Review of Criteria for Selection of Clinical Trials for a National Demonstration Model. 
  the American Association of Health Plans and the National Patient Advocate Foundation. Washington
• Symposium on Myelodysplasia and Bone Marrow Failure Syndromes. 
  The J.P. McCarthy Foundation, Dearborn, Michigan
• Influencing Medicare Payment Policy for Hematology Drugs. 
  Annual Meeting American Society of Hematology, New Orleans
• Issues Affecting Our Organizations: The American Society of Hematology. 
  The Oncology President’s Retreat. Virginia
• Committees on Practice in Hematology/Oncology Organizations. 
  Annual Meeting, American Society of Pediatric Hematology/Oncology
• The ASH Committee on Practice, Grassroots Breakfast. 
  Annual Meeting Society of Hematology, San Francisco
• Issues Affecting Our Organizations: The American Society of Hematology. 
  The Oncology President’s Retreat. Virginia
• Update in Bone Marrow Transplantation. 
  National Comprehensive Cancer Network Annual Conference, Fort Lauderdale
• Achieving Continuity in Cancer Care: From the Community Center to the Academic Center and Back. 
  Roundtable discussion: National Comprehensive Cancer Network Cancer Policy Summit. Tampa, FL
• Community Cancer Centers and the NCCN Oncology Outcomes Database. 
  National Comprehensive Cancer Network Annual Conference, Fort Lauderdale
• The ASH Committee on Practice, Grassroots Breakfast. 
  Hematology, Orlando, 2001; 2002
• What happened in 2003? 
  Annual Meeting American Society of Hematology, San Diego
• Join now to see all

Other

• Association of whole blood tacrolimus levels with acute graft-versus- host disease and nephrotoxicity in allogeneic marrow or blood stem cell transplant recipients. 
  Jacobson PA, Ratanatharathorn V, Ma M, Scalzo A, Wagner L, Schork MA, Silver SM, Adams PT, Uberti JP
• Allogeneic transplantation reduces disease progression compared to autologous transplantation for patients with myeloma. 
  Reynolds C, Ratanatharathorn V, Adams PT, Ayash L, Silver SM, Ferrara JL, Uberti J
• Allogeneic peripheral stem cell transplants in patients with chronic myeloid leukemia using tacrolimus for graft-versus-host disease prophylaxis. 
  Reynolds C, Ratanatharathorn V, Adams PT, Ayash L, Silver SM, Uberti JP
• Autologous and allogeneic stem cell transplantation: Experience at a community hospital. 
  Momin F, Uberti J, Ratanatharathorn V, Silver SM, Adams P, Ayash L, Akhtar A, Valdivieso M
• Comparative analysis of tacrolimus/methotrexate versus tacrolimus in allogeneic peripheral blood stem cell transplants: Engraftment, GVHD, relapse, and survival outc... 
  Reynolds C, Ratanatharathorn V, Adams P, Ayash L, Silver SM, Uberti J
• Allogeneic peripheral stem cell transplants in patients with chronic myeloid leukemia using tacrolimus for Graft-versus-Host Prophylaxis. 
  Reynolds C, Ratanatharathorn V, Adams P, Ayash L, Silver SM, Uberti JP
• Treatment of Patients with Febrile Neutropenia. 
  Shehab TM and Silver SM
• Allogeneic peripheral blood stem cell transplantation for high risk hematologic malignancies: the efficacy of tacrolimus for the prevention of acute graft-versus-hos... 
  Uberti JP, Adams PT, Silver SM, Jacobson PM, Scalzo A, Hammelef K, Ayash L, Ratanatharathorn V
• Risk-adjusted dose schedule of ganciclovir is effective for the prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients. 
  Jacobson PA; Ratanatharathorn V; Wu Y; Baker J; Levine J; Silver SM; Adams PT; Uberti JP
• Incorporating bone marrow transplantation into NCCN guidelines. 
  Vaughan WP, Silver SM, Beatty PG and Tallman MS
• Prophylaxis of Graft versus Host Disease with Tacrolimus in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation (AlloPBSCT). 
  Uberti JP, Silver SM, Adams PT, and Ratanatharathorn V
• Ex Vivo Expanded Progenitor Cell Transplantation in Patients with Breast Cancer. 
  Champlin R, Mehra R, Gajewski J, Khouri I, Geisler D, Davis M, Oba K, Thomas M, Armstrong RD, Douville J, Weber S, Silver SM, Muller T
• Expansion Potential of Patient CD34+ Cells is Significantly Lower and is More Stromal-Dependent than that of Normal Donors. 
  Koller MR, Manchel I, Palsson MA, Brott DA, Silver SM, and Palsson BO
• Phase I Evaluation of Ex Vivo Expanded Hematopoietic Cells Produced by Perfusion Cultures in Autologous Bone Marrow Transplantation. 
  Silver SM, Adams PT, Hutchinson RJ, Douville JW, Paul LA, Clarke MF, Palsson BO, and Emerson SG
• Hematology and Oncology: Issues in Medical Malpractice in Professional Liability Series, Medical Malpractice Issues: What You Need to Win Your Case. 
  Silver, SM
  Denver
• Hematology and Oncology: Issues in Medical Malpractice in Professional Liability Series, Medical Malpractice Issues: The Experts Analyze Medical Malpractice Cases. 
  Silver, SM
  San Francisco, CA
• From the President. 
  Silver SM, 2008, 2009
• Reduced-Intensity Regimen for Unrelated Donor Transplantation (UDT) as Salvage Therapy for Prior Recipients of Autologous Stem Cell Transplantation. 
  Ratanatharathorn V, Ayash L, Silver SM, Reynolds C, Becker M, Reddy P, Uberti, JP
• Acute Pain in a Sickle Cell Patient, Beyond Just a Vaso-Occlusive Pain Crisis. 
  Weber A, Silver SM, Campbell A, McNamara M, Kim C, SHM Annual Meeting, Journal of Hospital Medicine
• Measuring Distress in Caregivers of Hematopoietic Cell Transplant (HCT) Patients 5th Biennial Cancer Survivorship Research Conference. 
  Yi JC, Langer SL, Abrams JR, Silver SM, Tierney DK, Matous J, Wingard JR, Dansey R, McQuellon R, Syrjala KL, , Annals of Behavioral Medicine
• Multi-site Study of Caregiver Outcomes During Hematopoietic Cell Transplantation (HCT). 
  Yi JC, Syrjala KL, Abrams JR, Silver SM, Tierney K, Matous J, Wingard J, Dansey R, McQuellon R, Langer SL, Society of Behavioral Medicine's Annual Meeting
• Michigan Breast Oncology Quality Initiative (MiBOQI): A state-wide multidisciplinary breast cancer quality initiative. Concordance with quality measures. 
  Silver SM, Mehringer AM, Hayes A, Blayney DW, Ali H, Vandergrift JL, Breast Cancer Symposium, ASCO, San Francisco
• A Breast Cancer Quality Initiative for Community Practices. 
  Halman LJ, Stella P, Hayes A, Share D, Silver SM, Breast Cancer Symposium, ASCO, San Francisco
• Palifermin (A RHUKGF Molecule) is Safe and Well Tolerated in Patients with Hematologic Malignancies (HM) Undergoing High-Dose Chemoradiotherapy (HD-CRT). 
  Blazar, BR, Weisdorf, DJ, DeFor, TE, Goldman, AI, Silver, S, Ferrara, JLM
• Keratinocyte Growth Factor (Palifermin) in Combination with Tacrolimus and Methotrexate for the Prevention of Acute Graft- vs.-Host Disease (aGVHD) in Patients at H... 
  Reynolds CM, Levine JE, Uberti JP, Ratanatharathorn V, Ayash LJ, Silver SM, Yanik GA, Reddy PR, Kenneth CR, Michael BW, Raymond HJ, Ferrara LJ
• Join now to see all